Rheumatoid arthritis: Early diagnosis and treatment outcomes

Caspian Journal of Internal Medicine

Volumn 2, Issue 1, 2011, Pages 161-170

  Heidari, Behzad ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Early treament; New criteria; Outcome; Rheumatod arthritis

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; STEROID;

AGE; ARTHRALGIA; ARTICLE; BONE EROSION; BONE RADIOGRAPHY; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; EARLY DIAGNOSIS; EARLY INTERVENTION; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; GENDER; HAND DISEASE; HUMAN; JOINT SWELLING; LABORATORY TEST; MONOTHERAPY; MORNING STIFFNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PROGNOSIS; REMISSION; RHEUMATOID ARTHRITIS; SYNOVITIS; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84865339535     PISSN: 20086164     EISSN: 20086172     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Birch JT Jr, Bhattacharya S. Emerging trends in diagnosis and treatment of rheumatoid arthritis. Prim Care 2010; 37: 779-92
2. El Miedany Y, Youssef S, Mehanna AN, El Gaafary M. Development of a scoring system for assessment of outcome of early undifferentiated inflammatory synovitis. Joint Bone Spine 2008; 75: 155-62
3. Combe B. Progression in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2009; 23: 59-69
4. Gossec L, Combescure C, Rincheval N, et al. Relative Clinical influence of Clinical, Laboratory, and Radiological Investigations in Early Arthritis on the Diagnosis of Rheumatoid Arthritis. Data from the French Early Arthritis Cohort ESPOIR. J Rheumatol 2010; 37: 2486-92
5. Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis. Arthritis Rheum 2006; 55: 864-72
6. Aletaha D, Eberl G, Nell VP, Machold KP, Smolen JS. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years. Ann Rheum Dis 2002; 61: 630-4
7. Dixon WG, Symmons DPM. Does early arthritis exist? Best Practice Research Clinical Rheumatology 2005; 19: 37-53
8. Scott DL. Early rheumatoid arthritis, British Medical Bulletin 2007; 81and82: 97-114 DOI:10.1093/bmb/ldm0ll
9. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 2007; 146: 406-15
10. van der Helm-van Mil AH, Detert J, Le Cessie S, et al. Validation of a prediction rule for disease outcome in patients with recent - onset undifferentiated arthritis: moving toward individualized treatment decision - making. Arthritis Rheum 2008; 58: 2241-7
11. Finckh A. Early inflammatory arthritis versus rheumatoid arthritis. Curr Opin Rheumatol 2009; 21: 118-23
12. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324
13. Graudal N. The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins. Scand J Rheumatol Suppl 2004; 118: 1-38
14. van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH. Classification of rheumatoid arthritis: comparison of the 1987 American college of rheumatology crieria and 2010 American college of Rheumatology/European league Against Rheumatism criteria. Arthritis Rheum 2011; 63: 37-42
15. Verpoort KN, van Dongen H, Allaart CF, et al. Undifferentiated arthritis-disease course assessed in several inception cohortsClin Exp Rheumatol 2004; 22: S12-7.
16. de Rooy DP, van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH. Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic? Rheumatology (Oxford) 2011; 50: 93-700
17. Heidari B, Lotfi Z, Firouzjahi AR, Heidari P. Comparing the diagnostic value of anti-cyclic citrullinatied peptid antibody and rheumatoid factor for rheumatoid arthritis. Res med 2009; 33: 156-61
18. Heidari B, Firouzjahi A, Heidari P, Hajian K. The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis. Ann audi Med 2009; 29: 467-70
19. Schellekens GA, Visser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-63
20. Kumar A, Bansal M, Rivastava DN, et al. Long-term outcome of undifferentiated spondylarthropathy. Rheumatol Int 2001; 20: 221-4
21. van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 2004; 50: 709-15
22. van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis. Ann N Y Acad Sci 2008; 1143: 268-85
23. Raza K, Breese M, Nightingale P, et al. Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol 2005; 32: 237-8
24. Schumacher HR Jr, Habre W, Meador R, Hsia EC. Predictive factors in early arthritis: long-term follow-up. Semin Arthritis Rheum 2004; 33: 264-72
25. Quinn MA, Gough AK, Green MJ, et al. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology (Oxford). 2006; 45: 478-80
26. Waits JB. Rational use of laboratory testing in the initial evaluation of soft tissue and joint complaints. Prim Care 2010; 37: 673-89
27. Heidari B. Undifferentiated arthritis, the associated factors of progressive disease and treatment decision. Caspian J Intern Med 2010; 1: 79-88
28. Svensson B, Boonen A, Albertsson K, et al. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. Arthritis Rheum 2005; 52: 3360-70
29. Quinn MA, Green MJ, Marzo-Ortega H, et al. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum 2003; 48: 3039-45
30. Heidari B, Hajian K, Firous Jahi AR. Correlation between serum CRP levels and disease activity in Rheumatoid arthritis. Kowsar Med J 2004; 9: 208-20
31. Grassi W, De Angelis R, Lamanna G, Cervini C. The clinical features of rheumatoid arthritis. Eur J Radiol 1998; 27: S18-24
32. Heidari B, Abedi H, Firouzjahi A, Heidari P. Diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody for rheumatoid arthritis. Rheumatol Int 2009; 30: 1465-70
33. Heidari B, Heidari P, Tayebi MA. The value of changes in CRP and ESR for predicting treatment response in rheumatoid arthritis APLAR Journal of Rheumatol 2007; 10: 23-8
34. Farrant JM, O, Connor PJ, Grainger AJ. Advance imaging in rheumatoid arthritis, Part 1: synovitis. Skeletal Radiol 2007; 36: 269-279
35. Devauchelle-Pensec V, Saraux A, Alapetite S, Colin D, Le Goff P. Diagnostic value of radiographs of the hands and feet in early rheumatoid arthritis. Joint Bone Spine 2002; 69: 434-41
36. Machold KP, Stamm TA, Eberl GJ, et al. Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease. J Rheumatol 2002; 29: 2278-87
37. Wakefield RJ, Gibbon WW, Conaghan PG, et al. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum 2000; 43: 2762-70
38. Rahmani M, Chegini H, Najafizadeh R, et al. Detection of bone erosion in early rheumatoid arthritis: ultrasonography and conventional radiography versus non-contrast magnetic resonance imaging. Clin Rheumatol 2010; 29: 883-91
39. Tamai M, Kawakami A, Uetani M, et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum 2009; 61: 772-8
40. Sugumoto H, Takeda A, Hyodoh K. Early-Stage Rheumatoid Arthritis: Prospective Study of the Effectiveness of MR Imaging for Diagnosis. Radiology 2000; 216: 569-575
41. Goupille P, Roulot B, Akoka S, et al. Magnetic resonance imaging: a valuable method for the detection of synovial inflammation in rheumatoid arthritis. J Rheumatol 2001; 28: 35-40
42. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria. An American College of Rheumatoligy/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum 2010; 62: 2569-2581
43. Cush JJ. Early rheumatoid arthritis is there a window of opportunity? J Rheumatol 2007; 80: 1-7
44. Combe B. Suppl Early rheumatoid arthritis: strategies for prevention and management. Best Pract Res Clin Rheumatol 2007; 21: 27-42
45. Finckh A, Bansback N, Marra CA, et al. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. Ann Intern Med 2009; 151: 612-21
46. Sizova L. Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs. Br J Clin Pharmacol 2008; 66: 173-8
47. Korpela M, Laasonen L, Hannonen P, et al. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Arthritis Rheum 2004; 50: 2072-81
48. de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Verpoort KN, et al. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. Arthritis Rheum 2008; 58: 1293-8
49. Hafström I, Albertsson K, Boonen A, et al. Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying antirheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study. Ann Rheum Dis 2009; 68(4): 508-13
50. Kirwan JR, Bijlsma JW, Boers M, Shea BJ. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane database syst Rev 2007.
51. Wolfe F, Hawley DJ. Remission in rheumatoid arthritis. J Rheumatol 1985; 12: 245-52
52. Prevoo ML, Van Gestel AM, Van T Hof MA, et al. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria inr elation to the disease activity score Br J Rheumatol 1996; 35: 1101-5
53. Eberhardt K, Fex E. Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years. Br J Rheumatol 1998; 37: 1324-9
54. Lindqvist E, Saxne T, Geborek P, Eberhardt K. Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage. Ann Rheum Dis 2002; 61: 1055-9
55. Allaart CF, Breedveld FC, Dijkmans BA. Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study. J Rheumatol Suppl 2007; 80: 25-33